Zelenkofske Steven 4
4 · Cadrenal Therapeutics, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Zelenkofske Steven
Director
Transactions
- Award
Stock Options
2025-01-23+20,000→ 20,000 totalExercise: $19.79From: 2025-02-01Exp: 2035-01-22→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2025.